Atalanta Sosnoff Capital, LLC Pfizer Inc Transaction History

Atalanta Sosnoff Capital, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $809,775 - $1 Million	-17,700 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$41.32 - $61.25 $731,364 - $1.08 Million	17,700 New	17,700 $1.05 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $6.9 Million - $7.79 Million	-206,155 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $109,647 - $139,426	3,276 Added 1.61%	206,155 $7.59 Million
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $6.44 Million - $7.56 Million	202,879 New	202,879 $7.45 Million
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $22.5 Million - $29.2 Million	-693,143 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $6.83 Million - $7.66 Million	-184,607 Reduced 21.03%	693,143 $30 Million
Q1 2019 Apr 09, 2019	BUY	$37.5 - $41.2 $6.08 Million - $6.68 Million	162,212 Added 22.67%	877,750 $37.3 Million
Q4 2018 Jan 09, 2019	BUY	$38.47 - $43.86 $3.07 Million - $3.5 Million	79,799 Added 12.55%	715,538 $31.2 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $135,570 - $164,438	-3,933 Reduced 0.61%	635,739 $28 Million
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $242,798 - $258,847	-7,362 Reduced 1.14%	639,672 $23.2 Million
Q1 2018 Apr 06, 2018	SELL	$31.91 - $37.02 $600,641 - $696,827	-18,823 Reduced 2.83%	647,034 $23 Million
Q4 2017 Jan 09, 2018	SELL	$33.26 - $35.29 $459,919 - $487,990	-13,828 Reduced 2.03%	665,857 $24.1 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $21.1 Million - $23.2 Million	679,685	679,685 $24.3 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.